Cargando…

176. Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time

BACKGROUND: Inappropriate antibiotic use increases the risk of antimicrobial resistance and adverse events. Our institution adopts all elements recommended by the CDC to improve antimicrobial stewardship (AMS). Compliance with such elements requires education, coaching and decision support tools. Th...

Descripción completa

Detalles Bibliográficos
Autores principales: Taqi, Ahmad, Elarabi, Salwa, Fleisher, Jorge
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778119/
http://dx.doi.org/10.1093/ofid/ofaa439.220
_version_ 1783631063273177088
author Taqi, Ahmad
Elarabi, Salwa
Fleisher, Jorge
author_facet Taqi, Ahmad
Elarabi, Salwa
Fleisher, Jorge
author_sort Taqi, Ahmad
collection PubMed
description BACKGROUND: Inappropriate antibiotic use increases the risk of antimicrobial resistance and adverse events. Our institution adopts all elements recommended by the CDC to improve antimicrobial stewardship (AMS). Compliance with such elements requires education, coaching and decision support tools. The objective of the study intervention is to engage prescribers to critically evaluate and improve antibiotic utilization through renewal communication in the electronic medical record (EMR). METHODS: This is a single center study with a retrospective phase and prospective phase. During the intervention period from October 1st, 2019 to January 1st, 2020 the pharmacist monitored targeted antibiotics and initiated an AMS EMR note. Prescribers were then requested to evaluate the appropriateness of therapy utilizing pre-defined criteria developed in agreement with the infectious disease (ID) service at 48 hours, in-line with the EMR time-out alert. Adults receiving vancomycin (VAN), piperacillin/tazobactam (TAZ), cefepime (CEF) or meropenem (MPN) for at least 48 hours were included. The historical group included patients on the targeted antibiotics between July 1st, 2019 and September 30th, 2019. The primary outcome was median days of therapy (DOT). Secondary outcomes were median DOT per antibiotic, percentage of ID consults and percentage of antibiotic optimization. Statistical analyses were conducted using T-test and chi-square test for continuous and categorical variables respectively. RESULTS: A total of 81 and 72 patients were included in the intervention and historical groups respectively. No statistical difference in the primary outcome of median DOT was observed (4.5 vs 4, p=0.5). However, Non-significant numerical reductions in DOT were observed for VAN (3 vs 3.5, p=0.5), CEF (3 vs 4, p=0.6) and TAZ (3 vs 4, p=0.3), but not for MPN (6 vs 5, p=0.6). The intervention resulted in more ID consults when prescribing targeted antibiotics (59.3% vs 41.6%, p=0.03). In the intervention group, antibiotic treatment was optimized in 87.7% of patient, in which 39.6% were treatment de-escalation and discontinuation. CONCLUSION: Pharmacist clinical guidance through the electronic medical record can provide a powerful educational tool to promote adherence to antimicrobials best practice DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-7778119
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-77781192021-01-07 176. Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time Taqi, Ahmad Elarabi, Salwa Fleisher, Jorge Open Forum Infect Dis Poster Abstracts BACKGROUND: Inappropriate antibiotic use increases the risk of antimicrobial resistance and adverse events. Our institution adopts all elements recommended by the CDC to improve antimicrobial stewardship (AMS). Compliance with such elements requires education, coaching and decision support tools. The objective of the study intervention is to engage prescribers to critically evaluate and improve antibiotic utilization through renewal communication in the electronic medical record (EMR). METHODS: This is a single center study with a retrospective phase and prospective phase. During the intervention period from October 1st, 2019 to January 1st, 2020 the pharmacist monitored targeted antibiotics and initiated an AMS EMR note. Prescribers were then requested to evaluate the appropriateness of therapy utilizing pre-defined criteria developed in agreement with the infectious disease (ID) service at 48 hours, in-line with the EMR time-out alert. Adults receiving vancomycin (VAN), piperacillin/tazobactam (TAZ), cefepime (CEF) or meropenem (MPN) for at least 48 hours were included. The historical group included patients on the targeted antibiotics between July 1st, 2019 and September 30th, 2019. The primary outcome was median days of therapy (DOT). Secondary outcomes were median DOT per antibiotic, percentage of ID consults and percentage of antibiotic optimization. Statistical analyses were conducted using T-test and chi-square test for continuous and categorical variables respectively. RESULTS: A total of 81 and 72 patients were included in the intervention and historical groups respectively. No statistical difference in the primary outcome of median DOT was observed (4.5 vs 4, p=0.5). However, Non-significant numerical reductions in DOT were observed for VAN (3 vs 3.5, p=0.5), CEF (3 vs 4, p=0.6) and TAZ (3 vs 4, p=0.3), but not for MPN (6 vs 5, p=0.6). The intervention resulted in more ID consults when prescribing targeted antibiotics (59.3% vs 41.6%, p=0.03). In the intervention group, antibiotic treatment was optimized in 87.7% of patient, in which 39.6% were treatment de-escalation and discontinuation. CONCLUSION: Pharmacist clinical guidance through the electronic medical record can provide a powerful educational tool to promote adherence to antimicrobials best practice DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2020-12-31 /pmc/articles/PMC7778119/ http://dx.doi.org/10.1093/ofid/ofaa439.220 Text en © The Author 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
spellingShingle Poster Abstracts
Taqi, Ahmad
Elarabi, Salwa
Fleisher, Jorge
176. Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time
title 176. Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time
title_full 176. Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time
title_fullStr 176. Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time
title_full_unstemmed 176. Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time
title_short 176. Impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time
title_sort 176. impact of pharmacist electronic communication on the appropriateness of antimicrobial therapy at renewal time
topic Poster Abstracts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7778119/
http://dx.doi.org/10.1093/ofid/ofaa439.220
work_keys_str_mv AT taqiahmad 176impactofpharmacistelectroniccommunicationontheappropriatenessofantimicrobialtherapyatrenewaltime
AT elarabisalwa 176impactofpharmacistelectroniccommunicationontheappropriatenessofantimicrobialtherapyatrenewaltime
AT fleisherjorge 176impactofpharmacistelectroniccommunicationontheappropriatenessofantimicrobialtherapyatrenewaltime